Mohini Ranganathan

Dr. Mohini Ranganathan is a leading expert in the field of psychiatry, with a particular focus on schizophrenia, cannabis and cannabinoids, and neuroscience. As an Associate Professor of Psychiatry at Yale University, she has dedicated her career to advancing our understanding of these complex areas. Dr. Ranganathan earned her MBBS from Calicut Medical College in 1999, laying the foundation for her distinguished career in psychiatric research and education. Her work is characterized by a deep commitment to exploring the intricate relationships between cannabinoids and mental health disorders, particularly schizophrenia. Through her research, Dr. Ranganathan aims to unravel the potential therapeutic benefits and risks associated with cannabis use, contributing valuable insights to both the scientific community and public health policy. In recognition of her significant contributions to the field, Dr. Ranganathan was honored with the National Alliance on Mental Illness (NAMI) Exemplary Psychiatrist Award in 2022. This accolade underscores her dedication to improving mental health care and her impact on the lives of individuals affected by psychiatric disorders. Her ongoing research continues to shape the future of psychiatric treatment and understanding, making her a pivotal figure in the realm of mental health research.